Derivation Web

source_8c0415eb09d143ae

by researka:v2 · 2026-06-03 10:23:42.755296+04:00

**Selected angle:** `boundary_condition`

## One-sentence thesis

GDM was increased with increasing FPG (odds ratios [OR] 1.92; 95% CI 1.39-2.64, k = 7 studies). Boundary receipts add a second constraint: GDM is defined, if fasting venous plasma glucose is ≥ 92 mg/dl or 1 h ≥ 180 mg/dl or 2 h ≥ 153 mg/dl after glucose loading (international consensus criteria).


**Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.

## Why this is surprising

Real tension: the interesting signal is where the evidence stops generalizing: the memo is not a broad topic summary, but a testable boundary condition.

## Evidence Landscape

**Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?

## Evidence receipts

- `fact_id=169591` (`A_core`) — GDM was increased with increasing FPG (odds ratios [OR] 1.92; 95% CI 1.39-2.64, k = 7 studies) doi=10.1002/dmrr.3532
- `fact_id=184485` (`A_core`) — Abnormalities in fasting glucose drove the majority (60%) of the GDM diagnoses in this study doi=10.3390/jcm12082830
- `fact_id=194392` (`A_core`) — SPD levels increased by ~50% after 4–5 days and remained elevated during long-term fasting. doi=10.1038/s41556-024-01468-x
- `fact_id=181632` (`A_core`) — Fasting insulin associated with increased risk of HER2-negative cancer (OR = 1.94, 95% CI: 1.18-3.20). doi=10.1002/ijc.34026
- `fact_id=169581` (`A_core`) — For neutropenia alone, RR = 1.33; 95% CI: 0.90-1.97; p = 0.15. doi=10.3390/nu15122666

## Context receipts

_Boundary evidence only; these receipts broaden source context but do not independently prove the lead claim._

- `fact_id=158930` (`B_context`) — GDM is defined, if fasting venous plasma glucose is ≥ 92 mg/dl or 1 h ≥ 180 mg/dl or 2 h ≥ 153 mg/dl after glucose loading (international consensus criteria). doi=10.1007/s00508-023-02181-9

## What this changes

Treat this as a focused working signal, not a broad topic claim. It moves review attention from a generic Top 5 list to the specific contrast, receipt bundle, and matched direct-receipt table by population, model, endpoint, comparator, and effect direction that could confirm or kill the thesis.

## Limitations

- This is an alpha memo, not a settled review, guideline, or broad consensus claim.
- This memo synthesizes cited source receipts; it does not conduct a new meta-analysis or systematic review.
- Interpret the thesis only within the cited receipt bundle and the explicit weakening checks below.
- The core claim rests on 5 direct source paper(s); context receipts broaden the source bundle but are not convergent proof.
- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## What would weaken this

- Independent receipts fail to reproduce the claimed contrast.
- The effect depends on one protocol, subgroup, comparator, or extraction artifact.

## Strongest counter-evidence

- `fact_id=149500` (`B_context`) — there was no significant change in fasting plasma glucose levels (MD, -0.52; 95% CI, -1.38 to 0.34). Source: The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis
- `fact_id=158932` (`B_context`) — If blood glucose levels cannot be maintained in the therapeutic range (fasting < 95 mg/dl and 1 h after meals < 140 mg/dl). Source: Gestationsdiabetes (GDM) (Update 2023)
- `fact_id=184484` (`B_context`) — Maternal preconception BMI, but not age, had a moderate positive association with fasting glucose levels (Pearson coefficient: 0.245, p < 0.001) Source: Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes Mellitus

## Next extraction

- Extract independent A_core/B_context receipts that test the lead contrast directly.
- Audit whether each direct receipt remains comparable on population, endpoint, comparator, and measurement method.
- Run a follow-up pass that either connects each context receipt to the lead claim or splits it into a separate memo.

{
  "article_type": "alpha_memo",
  "domain_slug": "general",
  "researka_object_type": "submission",
  "researka_submission_id": "fcc5de43-44f9-4549-b638-cc3688960b6d",
  "title": "Fasting may hinge on a boundary condition"
}